Stock Screener: Medical , Medical-Biomed-Genetics

The medical or healthcare sector comprises of those stocks which are involved in the production of medical goods.
Medical-Biomed-Genetics belongs to the sector Medical. This industry has a Market Cap of 724.12B. The top rated companies for Medical-Biomed-Genetics industry are: Amgen (AMGN) , Celgene (CELG) , Gilead Sciences (GILD).

Select Sector Select Industry
Click on the column to sort the table.
Company Stock Rating Market Cap PE Ratio 1W 52W
Amgen (AMGN)
4.3/5 122.28B 16.19 -2.07% 11.06%
Biogen Inc (BIIB)
4.2/5 59.48B 16.24 0.01% 7.9%
Anika Therapeutics (ANIK)
4.2/5 610.74M 19.70 -0.42% -3.75%
Cambrex (CBM)
4.2/5 1.73B 20.43 -0.88% 18.21%
Gilead Sciences (GILD)
4.1/5 88.21B 6.79 -1.75% -26.07%
China Biologic Products (CBPO)
4.0/5 2.7B 26.47 -0.37% -9.78%
Myriad Genetics (MYGN)
4.0/5 1.3B 23.35 1.73% -46.69%
Celgene (CELG)
3.9/5 95.86B 49.75 -2.47% 22.72%
Regeneron Pharma (REGN)
3.9/5 38.72B 49.08 -2.36% 0.59%
PDL BioPharma (PDLI)
3.8/5 336.08M 5.08 -9.17% -36.33%
ANI Pharma (ANIP)
3.8/5 527.81M 135.27 1.64% 41.29%
Enzo Biochem (ENZ)
3.8/5 366.17M 12.58 6.71% 86.5%
Innoviva (INVA)
3.8/5 1.41B 24.71 -2.91% 8.53%
Incyte (INCY)
3.7/5 28.32B 258.59 -5.98% 100.17%
Illumina (ILMN)
3.7/5 24.53B 54.50 4.34% 9.81%
Alexion Pharma (ALXN)
3.7/5 27.01B 68.15 -0.78% -10.46%
Emergent Biosolutions (EBS)
3.6/5 1.15B 30.34 -5.1% -14.61%
BioTechne Corporation (TECH)
3.6/5 3.86B 49.44 -0.14% 10.6%
AMAG Pharma (AMAG)
3.6/5 741.72M - -2.87% 2.71%
Repligen (RGEN)
3.5/5 1.17B 101.88 -0.94% 32.57%
VIVUS (VVUS)
3.5/5 115.09M 5.00 0 -1.79
Integra LifeSciences (IART)
3.4/5 3.17B 46.46 -1% 32.79%
Qiagen (QGEN)
3.4/5 6.49B 85.09 -0.89% 28.21%
MiMedx (MDXG)
3.4/5 970.86M 82.73 1.79% 10.3%
Cytokinetics (CYTK)
3.3/5 523.71M 42.00 0.8% 89.19%
Applied Genetic Technologies (AGTC) 3.2/5 119.35M 11.67 -7.64% -51.46%
Ligand Pharma (LGND)
3.2/5 2.17B - -3.72% 2.21%
Horizon Pharma (HZNP)
3.2/5 2.36B - -4.52% -10.3%
Heska (HSKA)
3.2/5 692.82M 69.04 2.12% 247.85%
Osiris Therapeutics (OSIR) 3.1/5 133.33M 78.00 1.29% -22.02%
Vertex Pharma (VRTX)
2.9/5 22.12B - -1.46% 11.67%
Bio-Rad Labs (BIO.B)
2.9/5 5.83B 49.39 0 45.93
Momenta Pharma (MNTA)
2.8/5 962.83M - -2.87% 59.22%
Exelixis (EXEL)
2.7/5 5.91B - -5.13% 417.57%
Retrophin (RTRX)
2.7/5 667.79M - -4.82% 38.9%
Acorda Therapeutics (ACOR)
2.7/5 1.18B - -5.93% -1.51%
Alkermes (ALKS)
2.5/5 8.95B - -1.34% 86.68%
Genomic Health (GHDX)
2.5/5 1.06B - -1.41% 35.04%
Vanda Pharmaceuticals (VNDA)
2.5/5 619.65M - 2.12% 88.4%
Array BioPharma (ARRY)
2.4/5 1.56B - -6.06% 230.77%
Sinovac Biotech (SVA)
2.4/5 327.54M - -1.71% -9.43%
Seattle Genetics (SGEN)
2.4/5 9.01B - -6.37% 83.65%
EXACT Sciences (EXAS)
2.4/5 2.27B - -0.68% 242.21%
Galapagos (GLPG)
2.4/5 3.73B 66.97 0.28% 100.32%
NeoGenomics (NEO)
2.3/5 597.48M - -3.16% 20.85%
Amarin (AMRN)
2.3/5 854.27M - -4.49% 120%
Halozyme Therapeutics (HALO)
2.3/5 1.75B - -6.11% 52.54%
Organovo (ONVO)
2.3/5 314.28M - -5.02% 45.67%
Kamada (KMDA)
2.3/5 249.67M - -0.72% 77.38%
Arna Pharma (ARNA)
2.3/5 355.93M - -2.99% -20.22%
Cellectis (CLLS)
2.2/5 801.52M - -5.66% -15.17%
Geron (GERN)
2.2/5 335.83M - 0.47% -25.87%
Nymox Pharmaceutical (NYMX) 2.2/5 149.19M - -4.46% 45.91%
Five Prime Therapeutics (FPRX)
2.2/5 1.01B - -8.24% -3.56%
Regenxbio (RGNX)
2.2/5 531.59M - -16.39% 104.57%
Keryx Biopharma (KERX)
2.2/5 594.33M - -10.17% 23.63%
Aduro BioTech (ADRO)
2.1/5 703.78M - -10.96% -16.25%
BioMarin Pharma (BMRN)
2.1/5 15.01B - -2.92% 8.04%
Lexicon Pharma (LXRX)
2.1/5 1.48B - -4.31% 22.31%
Uniquire (QURE)
2.1/5 144.54M - -3.65% -51.38%
Coherus Biosciences (CHRS)
2.1/5 1.12B - -9.07% 11.03%
Compugen (CGEN)
2.1/5 214.75M - -1.14% -25.26%
Spark Therapeutics (ONCE)
2.0/5 1.63B - -8.74% 63.34%
Inovio Pharma (INO)
2.0/5 440.9M - -0.82% -23.42%
NewLink Genetics (NLNK)
2.0/5 593.09M - -10.31% 14.21%
Curis (CRIS)
2.0/5 405.8M - -0.67% 97.33%
Sorrento Therapeutics (SRNE)
2.0/5 213.73M - -2.38% -17.67%
The Medicines Company (MDCO)
1.9/5 3.57B - -1.19% 61.9%
Celldex Therapeutics (CLDX)
1.9/5 402.91M - -1.19% -5.67%
Intellia Therapeutics (NTLA)
1.9/5 475.14M - -8.92% -40.86%
Kite Pharma (KITE)
1.9/5 4.09B - -9.54% 81.35%
Stemline Therapeutics (STML)
1.9/5 212.96M - -11.98% 86.12%
Blueprint Medicines (BPMC)
1.8/5 1.36B - 6.16% 167.4%
Merrimack Pharma (MACK)
1.8/5 394.32M - -6.23% -63.07%
Evogene (EVGN) 1.8/5 131.74M - 1.17% -21.42%
Acceleron Pharma (XLRN)
1.8/5 1.02B - -4.49% 10.62%
Cellular Biomedicine (CBMG) 1.8/5 159.23M - -0.44% -32.12%
Arbutus Biopharma (ABUS) 1.8/5 173.32M - -4.48% -19.8%
Alnylam Pharma (ALNY)
1.8/5 4.58B - -12.13% -12.96%
Juno Therapeutics (JUNO)
1.8/5 2.15B - -11.6% -45.08%
Idera Pharma (IDRA)
1.8/5 360.81M - 11.21% 24.62%
Agenus (AGEN)
1.8/5 385.45M - -5.37% -0.77%
Intercept Pharma (ICPT)
1.7/5 2.88B - -5.53% -7.36%
Prothena (PRTA)
1.7/5 1.82B - -3.39% 30.24%
Achillion Pharma (ACHN)
1.7/5 518.18M - -6.23% -49.05%
Editas (EDIT)
1.7/5 784.67M - -14.06% -38.49%
Cara Therapeutics (CARA)
1.7/5 455.69M - 3.65% 186.99%
Peregrine Pharma (PPHM) 1.7/5 201.37M - -0.56% 72.2%
CytomX Therapeutics (CTMX)
1.7/5 637.02M - -5.82% 39.53%
Mesoblast (MESO)
1.7/5 746.36M - 4.6% -4.81%
Ophthotech (OPHT) 1.7/5 121.03M - 0 -91.41
Adverum (ADVM) 1.7/5 109.36M - -1.85% -47.94%
bluebird bio (BLUE)
1.7/5 3.55B - -3.72% 123.66%
Acadia Pharma (ACAD)
1.6/5 4.18B - -6.35% 71.49%
Abeona Therapeutics (ABEO)
1.6/5 187.81M - -4.95% 79.78%
ZIOPHARM Oncology (ZIOP)
1.6/5 777.05M - -5.77% -17.88%
Immunomedics (IMMU)
1.6/5 703.31M - 6.34% 178.54%
Epizyme (EPZM)
1.6/5 987.32M - -0.29% 59.98%
MyoKardia (MYOK)
1.6/5 436.7M - 0 59.91
OncoMed Pharma (OMED)
1.5/5 342.94M - -5.15% -5.93%
MIRAGEN THERAP (MGEN)
1.5/5 238.35M - -1.96% 60.09%
Sangamo BioSciences (SGMO)
1.5/5 297.67M - -5.75% -25.32%
Advaxis (ADXS)
1.5/5 316.72M - -6.7% -9.15%
Proteostasis (PTI)
1.5/5 259.08M - -14.42% 5.7%
Revance (RVNC)
1.5/5 581.98M - -4.15% 13.19%
Merus (MRUS)
1.5/5 406.47M - -13.72% 144.92%
Ascendis Pharma (ASND)
1.4/5 946.69M - -4.23% 60.9%
Adaptimmune Therapeutics (ADAP)
1.4/5 302.25M - -7.36% -45.96%
Dynavax Technologies (DVAX) 1.4/5 263.9M - 0 -67
MediciNova (MNOV)
1.4/5 200.61M - -1.68% 0.86%
Novavax (NVAX)
1.4/5 345.37M - -4.55% -75.68%
Vtv Therapeutics (VTVT)
1.4/5 194.28M - -2.31% 7.85%
Reata Pharma (RETA)
1.4/5 360.14M - -5.23% 98.16%
Sarepta Therapeutics (SRPT)
1.4/5 1.63B - -1.71% 62.22%
Syndax Pharma (SNDX)
1.4/5 236.44M - -9.39% 2.46%
NantKwest (NK)
1.4/5 282.28M - -4.51% -58.15%
MannKind (MNKD)
1.3/5 186.76M - -14.09% -82.09%
Wave Life Sciences (WVE) 1.3/5 612.12M - -3.61% 74.71%
Xenon Pharma (XENE) 1.3/5 176.67M - -43.64% -30.65%
Paratek Pharma (PRTK)
1.3/5 382.51M - -3.35% 8.27%
Amicus Therapeutics (FOLD)
1.3/5 1.02B - -0.34% -6.7%
Alder BioPharma (ALDR)
1.3/5 1.04B - -3.17% 24.27%
Insmed (INSM)
1.3/5 970.66M - -2.95% 34.32%
Beigene (BGNE)
1.3/5 1.16B - -8.24% 29.5%
Intra-Cellular Therapies (ITCI)
1.2/5 642.47M - -0.67% -42.3%
Fate Therapeutics (FATE) 1.2/5 192.04M - -4.41% 153.72%
Trevena (TRVN)
1.2/5 205.1M - -1.11% -52.16%
Pharming Group (PHGUF) - 153.57M - -4.71% -4.71%
Power 3 Medical (PWRM) - 0.06M - N/A N/A
Regenerx Biopharma (RGRX) - 33.1M - -3.13% -55.07%
VG Life Sciences (VGLS) - 1.19M - 10% -63.33%
CSL Ltd (CMXHY) - 30.75B - N/A N/A
Volitionrx (VNRX) - 105.3M - -7.11% 6.3%
Dendreon (DNDNQ) - 5.4M - N/A N/A
Taxus Cardium Pharma (CRXM) - 2.85M - -11.11% 11.11%
Mymetics (MYMX) - 5.68M - 0 11.11
GeneLink (GNLKQ) - 0.19M - 0 0
Neurologix (NRGXQ) - 0.04M - 0 0
Accentia BioPharma (ABPI) - 0.01M - N/A N/A
Starpharma (SPHRY) - 186.51M - 1.98% 7.29%
Oragenics (OGEN) - 21.19M - 4.35% -49.47%
Prodite Pharma (PPMD) - 0.35M - 0 248
Gliatech (GLIAQ) - 0M - N/A N/A
SCOLR Pharma (SCLR) - 0.04M - N/A N/A
Cellcyte Genetics (CCYG) - 0.14M - 0 -50
Vitro Diagnostics (VODG) - 1.31M - -18.99% -8.57%
Cormedix (CRMD) - 70.86M - -3.41% -28.57%
Amarillo (AMAR) - 4.28M - -8% 27.78%
Ultragenyx Pharma (RARE) - 3B - -17.34% 19.15%
Neuro Hitech (NHPI) - 0M - 0 0
Igene Biotechnology (IGNE) - 0.31M - 0 0
PROTAGENIC THER (PTIX) - 22.57M - 0 -84.19
Tengion (TNGNQ) - 0.08M - 0 0
Bionovo (BNVIQ) - 0.02M - 0 0
Atara Bio (ATRA) - 610.89M - -2.35% 23.15%
Palatin Technologies (PTN) - 45.52M - -2.98% -33.47%
Genitope (GTOPQ) - 0.06M - 0 0
Deltagen (DGEN) - 0M - 0 -100
Unigene Laboratories (UGNEQ) - 0.08M - -100 0
Helix Biomedix (HXBM) - 7.84M - 0 0.43
USA Equities Corp (USAQ) - 0.02M - 0 -96.67
Marina Biotech (MRNA) - 21.55M - 8.11% 73.91%
Vital Therapies (VTL) - 128.58M - -15.38% -55.95%
Nanobac Pharma (NNBP) - 0.2M - 0 0
Pfenex (PFNX) - 130.89M 24.35 -14.89% -31.62%
IR Biosciences (IRBS) - 0M - 0 -100
Advanced Life Sciences (ADLS) - 0M - 0 -100
BioForce Nanosciences (BFNH) - 0.28M - 0 0
BioTime (BTX) - 358.06M 9.38 -7.8% 27.09%
Protalix Biotherapeutics (PLX) - 141.51M - -2.61% 31.92%
Rexahn Pharma (RNN) - 103.17M - -2.17% 42.86%
Health Discovery (HDVY) - 2.09M - -20% -74.19%
VIA Pharma (VIAP) - 0.08M - 0 33.33
Respirerx Pharma (RSPI) - 7.07M - -9.09% -52.82%
Polymedix (PYMXQ) - 0M - N/A N/A
iBio (IBIO) - 36.53M - -6.67% -27.59%
Savient Pharma (SVNTQ) - 0.59M - N/A N/A
Myrexis (MYRX) - 1.83M - -32.05% -24.29%
Introgen Therapeutics (INGNQ) - 0M - N/A N/A
Akesis Pharma (AKESQ) - 0.03M - N/A N/A
Bellus Health (BLUSF) - 13.19M - 2.03% -83.04%
Oncolytics Biotech (ONCYF) - 52.88M - -3.25% 31.47%
Protein Polymer (PPTIQ) - 0.06M - 0 -100
Wowi (WOWU) - 9.73B - 55.56% 337.5%
Genmab (GNMSF) - 12.15B 108.62 -3.61% 56.25%
Viralytics (VRACY) - 216.26M - 0 83.67
Cel-Sci Corporation (CVM) - 18.14M - -11.58% -84.39%
Nicox (NICXF) - 236.3M - 0 23.21
Interleukin Genetics (ILIU) - 26.38M - -3.36% 91.67%
Insite Vision (INSV) - 45.85M - N/A N/A
Synthetic Biologics (SYN) - 84.32M - -6.42% -68.33%
Avax Technologies (AVXT) - 2.07M - 33.33% -75%
Immune Therapeutics (IMUN) - 8.1M - 0 -77.71
Biocurex (BOCX) - 0M - N/A N/A
Panacos Pharma (PANC) - 0.03M - -100 0
DBV Tech (DBVT) - 1.68B - -0.51% 14.98%
Provectus Biopharma (PVCT) - 13.9M - 65.71% -84.53%
Regenicin (RGIN) - 23.64M - -5.06% 614.29%
Guangzhou Pharma (GZPHY) - 726.88M - 0 0